382 related articles for article (PubMed ID: 18695915)
21. Onopordum cynarocephalum induces apoptosis and protects against 1,2 dimethylhydrazine-induced colon cancer.
El-Najjar N; Saliba N; Talhouk S; Gali-Muhtasib H
Oncol Rep; 2007 Jun; 17(6):1517-23. PubMed ID: 17487413
[TBL] [Abstract][Full Text] [Related]
22. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Ji BS; He L
J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
[TBL] [Abstract][Full Text] [Related]
23. Pomolic acid may overcome multidrug resistance mediated by overexpression of anti-apoptotic Bcl-2 proteins.
Fernandes J; Weinlich R; Castilho RO; Amarante-Mendes GP; Gattass CR
Cancer Lett; 2007 Jan; 245(1-2):315-20. PubMed ID: 16517065
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-beta production.
Chorna I; Bilyy R; Datsyuk L; Stoika R
Exp Oncol; 2004 Jun; 26(2):111-7. PubMed ID: 15273662
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
27. The nitroxide Tempol modulates anthracycline resistance in breast cancer cells.
Gariboldi MB; Terni F; Ravizza R; Meschini S; Marra M; Condello M; Arancia G; Monti E
Free Radic Biol Med; 2006 Apr; 40(8):1409-18. PubMed ID: 16631531
[TBL] [Abstract][Full Text] [Related]
28. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis.
Yu ST; Chen TM; Chern JW; Tseng SY; Chen YH
Anticancer Drugs; 2009 Jun; 20(5):382-8. PubMed ID: 19318911
[TBL] [Abstract][Full Text] [Related]
30. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
31. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
Shen J; Zhang W; Wu J; Zhu Y
Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
[TBL] [Abstract][Full Text] [Related]
32. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
Azab SS; Salama SA; Abdel-Naim AB; Khalifa AE; El-Demerdash E; Al-Hendy A
Breast Cancer Res Treat; 2009 Jan; 113(1):9-19. PubMed ID: 18228136
[TBL] [Abstract][Full Text] [Related]
33. CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53.
Zhang YF; Li XH; Shi YQ; Wu YY; Li N; He Q; Ji Q; Wang RQ; Yang SM; Fang DC
Oncol Rep; 2011 Apr; 25(4):1091-8. PubMed ID: 21240465
[TBL] [Abstract][Full Text] [Related]
34. Circumvention of tumor multidrug resistance by a new annonaceous acetogenin: atemoyacin-B.
Fu LW; Pan QC; Liang YJ; Huang HB
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):435-9. PubMed ID: 10678092
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells.
Lukyanova NY
Exp Oncol; 2010 Mar; 32(1):10-4. PubMed ID: 20332764
[TBL] [Abstract][Full Text] [Related]
36. Molecular determinants of intrinsic resistance to doxorubicin in human cancer cell lines.
Gariboldi MB; Ravizza R; Riganti L; Meschini S; Calcabrini A; Marra M; Arancia G; Dolfini E; Monti E
Int J Oncol; 2003 May; 22(5):1057-64. PubMed ID: 12684672
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.
Yeh PY; Chuang SE; Yeh KH; Song YC; Chang LL; Cheng AL
Oncogene; 2004 Apr; 23(20):3580-8. PubMed ID: 15116093
[TBL] [Abstract][Full Text] [Related]
38. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
39. [Effect of neferine on adriamycin-resistance of thermotolerant hepatocarcinoma cell line HepG2/thermotolerance].
Ai XH; Tang XQ; Liu YP; Liu HQ; Dong L
Ai Zheng; 2007 Apr; 26(4):357-60. PubMed ID: 17430651
[TBL] [Abstract][Full Text] [Related]
40. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
Lo YL; Ho CT; Tsai FL
Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]